| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.027 | 0.6 |